Pope JE - Search Results

1

Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A. Pease C, et al. Among authors: pope je. Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004. Epub 2010 Dec 17. Semin Arthritis Rheum. 2011. PMID: 21168187

2

Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.

Pope JE, Hong P, Koehler BE. Pope JE, et al. J Rheumatol. 2002 Feb;29(2):255-60. J Rheumatol. 2002. PMID: 11838842

3

Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.

Haraoui B, Keystone EC, Thorne JC, Pope JE, Chen I, Asare CG, Leff JA. Haraoui B, et al. Among authors: pope je. J Rheumatol. 2004 Dec;31(12):2356-9. J Rheumatol. 2004. PMID: 15570634 Clinical Trial.

4

Osteoporosis in scleroderma.

Loucks J, Pope JE. Loucks J, et al. Among authors: pope je. Semin Arthritis Rheum. 2005 Feb;34(4):678-82. doi: 10.1016/j.semarthrit.2004.08.006. Semin Arthritis Rheum. 2005. PMID: 15692961 Review.

5

Scleroderma treatment differs between experts and general rheumatologists.

Pope JE, Ouimet JM, Krizova A. Pope JE, et al. Arthritis Rheum. 2006 Feb 15;55(1):138-45. doi: 10.1002/art.21714. Arthritis Rheum. 2006. PMID: 16463426 Free article. No abstract available.

6

Campylobacter reactive arthritis: a systematic review.

Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Pope JE, et al. Semin Arthritis Rheum. 2007 Aug;37(1):48-55. doi: 10.1016/j.semarthrit.2006.12.006. Epub 2007 Mar 13. Semin Arthritis Rheum. 2007. PMID: 17360026 Free PMC article. Review.

7

Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment.

Villela R, Yuen SY, Pope JE, Baron M; Canadian Scleroderma Research group. Villela R, et al. Among authors: pope je. Arthritis Rheum. 2008 May 15;59(5):706-13. doi: 10.1002/art.23567. Arthritis Rheum. 2008. PMID: 18438906 Free article.

8

Determinants of morbidity and mortality of systemic sclerosis in Canada.

Al-Dhaher FF, Pope JE, Ouimet JM. Al-Dhaher FF, et al. Among authors: pope je. Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15. Semin Arthritis Rheum. 2010. PMID: 18706680

9

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M; Canadian Network For Improved Outcomes in Systemic Lupus. Fortin PR, et al. Arthritis Rheum. 2008 Dec 15;59(12):1796-804. doi: 10.1002/art.24068. Arthritis Rheum. 2008. PMID: 19035431 Free article. Clinical Trial.

10

The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.

Pope JE, Khanna D, Norrie D, Ouimet JM. Pope JE, et al. J Rheumatol. 2009 Feb;36(2):254-9. doi: 10.3899/jrheum.080479. J Rheumatol. 2009. PMID: 19132791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters